CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands		Total	At-the-Market Offering	2022 Subscription Agreement	Underwriting Agreement	2023 Subscription Agreement	Series B	Series D	Series E	Common Stock		Common Stock At-the-Market Offering	Common Stock 2022 Subscription Agreement	Common Stock Underwriting Agreement	Common Stock 2023 Subscription Agreement	Additional Paid-In Capital	Additional Paid-In Capital At-the-Market Offering	Additional Paid-In Capital 2022 Subscription Agreement	Additional Paid-In Capital Underwriting Agreement	Additional Paid-In Capital 2023 Subscription Agreement	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Preferred stock, beginning balance (in shares) at Dec. 31, 2020	[1]	957,159,704
Preferred stock, beginning balance at Dec. 31, 2020		$ 2,494,076
Increase (Decrease) in Temporary Equity [Roll Forward]
Repurchase of Series B convertible preferred stock (in shares)	[1]						(3,525,365)
Issuance of Series D convertible preferred stock upon exercise of warrants (in shares)	[1]							1,546,799
Issuance of Series D convertible preferred stock upon exercise of warrants								$ 12,936
Issuance of Series E convertible preferred stock (in shares)	[1]								200,728,229
Issuance of Series E convertible preferred stock									$ 3,206,159
Stock-based compensation related to Series E convertible preferred stock									$ 123,614
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)	[1]	(1,155,909,367)
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization		$ (5,836,785)
Preferred stock, ending balance (in shares) at Dec. 31, 2021	[1]	0
Preferred stock, ending balance at Dec. 31, 2021		$ 0
Beginning balance (in shares) at Dec. 31, 2020	[1]									28,791,702
Beginning balance at Dec. 31, 2020		(1,318,777)								$ 3						$ 38,113					$ 0	$ 0	$ (1,356,893)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(2,579,761)																					(2,579,761)
Issuance of Series E convertible preferred stock		(2,151,613)														(22,395)							(2,129,218)
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)	[1]									1,155,909,367
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization		5,836,785								$ 116						5,836,669
Issuance of common stock (in shares)	[1]									425,395,023
Issuance of common stock		3,590,956								$ 42						3,590,914
Other comprehensive income (loss)		0
Tax withholding payments for net settlement of employee awards		$ (22,063)														(22,063)
Treasury stock repurchase (in shares)		(857,825)								(857,825)	[1]
Treasury stock repurchase		$ (20,716)																			(20,716)
Issuance of common stock upon vesting of employee RSUs (in shares)	[1]									601,176
Issuance of common stock upon exercise of common stock warrants (in shares)	[1]									26,640,121
Issuance of common stock upon exercise of common stock warrants		173,273								$ 3						173,270
Redemption of public warrants		(4)														(4)
Issuance of common stock upon exercise of stock options (in shares)	[1]									11,076,026
Issuance of common stock upon exercise of stock options		8,132								$ 1						8,131
Stock-based compensation		393,143														393,143
Ending balance (in shares) at Dec. 31, 2021	[1]									1,647,555,590
Ending balance at Dec. 31, 2021		$ 3,909,355								$ 165						9,995,778					(20,716)	0	(6,065,872)
Preferred stock, beginning balance (in shares) at Jul. 22, 2021		437,182,072
Beginning balance (in shares) at Jul. 22, 2021		451,295,965
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)										1,155,909,367
Ending balance (in shares) at Jul. 23, 2021		1,618,621,534
Preferred stock, beginning balance (in shares) at Dec. 31, 2021	[1]	0
Preferred stock, ending balance (in shares) at Dec. 31, 2022	[1]	0
Preferred stock, ending balance at Dec. 31, 2022		$ 0
Beginning balance (in shares) at Dec. 31, 2021	[1]									1,647,555,590
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(1,304,460)																					(1,304,460)
Issuance of common stock (in shares)	[1]											56,203,334	85,712,679
Issuance of common stock			$ 594,317	$ 915,000								$ 6	$ 9				$ 594,311	$ 914,991
Other comprehensive income (loss)		(11,572)																				(11,572)
Tax withholding payments for net settlement of employee awards		$ (218,789)														(218,789)
Treasury stock repurchase (in shares)		0
Issuance of common stock upon vesting of employee RSUs (in shares)	[1]									15,217,096
Issuance of common stock upon vesting of employee RSUs		$ 0								$ 1						(1)
Issuance of common stock under employee stock purchase plan (in shares)	[1]									2,106,158
Issuance of common stock under employee stock purchase plan		24,562														24,562
Issuance of common stock upon exercise of stock options (in shares)	[1]									22,519,879
Issuance of common stock upon exercise of stock options		17,788								$ 2						17,786
Stock-based compensation		$ 423,500														423,500
Ending balance (in shares) at Dec. 31, 2022		1,829,314,736								1,829,314,736	[1]
Ending balance at Dec. 31, 2022		$ 4,349,701								$ 183						11,752,138					(20,716)	(11,572)	(7,370,332)
Preferred stock, ending balance (in shares) at Dec. 31, 2023	[1]	0
Preferred stock, ending balance at Dec. 31, 2023		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(2,828,420)																					(2,828,420)
Issuance of common stock (in shares)	[1]													173,544,948	265,693,703
Issuance of common stock					$ 1,184,224	$ 1,812,641								$ 17	$ 27				$ 1,184,207	$ 1,812,614
Other comprehensive income (loss)		16,422																				16,422
Tax withholding payments for net settlement of employee awards		$ (17,615)														(17,615)
Treasury stock repurchase (in shares)		0
Issuance of common stock upon vesting of employee RSUs (in shares)	[1]									16,947,760
Issuance of common stock upon vesting of employee RSUs		$ 0								$ 2						(2)
Issuance of common stock under employee stock purchase plan (in shares)	[1]									4,748,875
Issuance of common stock under employee stock purchase plan		$ 23,836														23,836
Issuance of common stock upon exercise of stock options (in shares)		9,003,642								9,003,642	[1]
Issuance of common stock upon exercise of stock options		$ 10,343								$ 1						10,342
Stock-based compensation		$ 300,560														300,560
Ending balance (in shares) at Dec. 31, 2023		2,299,253,664								2,299,253,664	[1]
Ending balance at Dec. 31, 2023		$ 4,851,692								$ 230						$ 15,066,080					$ (20,716)	$ 4,850	$ (10,198,752)

[1] The number of shares of convertible preferred stock and common stock issued and outstanding prior to the Merger have been retroactively adjusted by the Exchange Ratio (as defined in Note 4 “Reverse Recapitalization”) to give effect to the reverse recapitalization treatment of the Merger. See Note 1 “Description of Business” and Note 4 “Reverse Capitalization” for more information.